































The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 




























































Intrahepatic	 biliary	 cystadenoma	 was	 initially	 described	 in	 1887	 with	 the	 first	 resection	
performed	in	1892.	In	1958	Edmondson	defined	strict	criteria	as	definition	of	cystadenoma	
which	included	the	lesion	to	be	multilocular	with	ovarian-like	stroma.	In	1994	Devaney	et	al.	
evaluated	 the	 pathology	 of	 70	 cases	 and	 observed	 the	 presence	 of	 ovarian	 stroma	 to	 be	
inconsistent	 and	proposed	 that	 biliary	 cystadenomas	 could	occur	with	or	without	 ovarian	
stroma.1,2	The	World	Health	Organization	Classification	of	Tumours	3rd	Edition	published	in	
2000	 described	 the	 disease	 entity	 biliary	 cystadenomas	 and	 cystadenocarcinomas.3	 There	
however	 remains	confusion	 in	 the	 literature	and	biliary	cystadenomas	were	 reclassified	 in	
the	4th	Edition	published	in	2010	as	biliary	mucinous	cystic	neoplasms	(BMCNs),	either	non-
invasive	 or	 invasive.	 BMCNs	 have	 no	 biliary	 communication	 and	 should	 have	 ovarian-like	




More	 than	90%	of	 all	 BCMNs	occur	 in	 females.	Many	 studies	with	more	 than	10	patients	
include	 only	 women.4,6	 This	 almost	 exclusive	 female	 predominance	 suggests	 a	 hormonal	






Formal	 surgical	 resection	 with	 negative	 margins	 remains	 the	 recommended	 treatment.	




aged	women	who	have	well	 encapsulated	multilocular	 cystic	 liver	 tumours.	The	histologic	
classification	has	evolved	considerably	and	surgical	resection	still	offers	optimal	treatment.	










used	 to	 identify	 patients	 who	 underwent	 surgery	 for	 BMCNs	 in	 the	 HPB	 Surgical	 Unit	 at	



















Only	 data	 from	 the	 HREC	 approved	 database	 (R024/2014)	 will	 be	 used.	 No	 risks	 to	 the	









































































































































































Cystic	lesion	 Demography	 Clinical	picture	 Blood/cyst	fluid	analyses	













































































































































































































































































































































































































Surgical	 and	 Medical	 Gastroenterology	 Units,	 Departments	 of	 Surgery	 and	 Medicine,	




















































































































1	 46	 RUQ	pain	 Jaundice	and	epigastric	mass	 15	 Central	(4,5)	
2	 47	 N	and	V,	LOW	 Palpable	epigastric	mass	 25	 Right	(5,6)	
3	 39	 RUQ	pain	 None	 2,5	 Right	(5)	
4	 48	 Epigastric	discomfort	 Palpable	epigastric	mass	 NA	 Central	(2,3,4,5)	
5	 74	 Epigastric	discomfort	 None	 NA	 Left	(2,3)	
6	 22	 RUQ	pain	 Jaundice	and	epigastric	mass	 12	 Central	(4,5)	
7	 32	 Biliary	colic	 None	 10	 Left	(3)	
8	 45	 Abdominal	distention	 Palpable	epigastric	mass	 21	 Central	(4,5,6)	
9	 35	 RUQ	pain	 Previous	surgery	 8	 NA	
10	 56	 RUQ	pain	 Palpable	epigastric	mass	 10	 Right	(5)	
11	 44	 Epigastric	discomfort	 NA	 NA	 Right	(5,6)	
12	 38	 Abdominal	distention	 Palpable	epigastric	mass	 30	 Central	(4,5,8)	







	 	 Anatomical	liver	resection		 	 	 	 6	
	 	 Non-anatomical	liver	resection	
	 	 	 Complete	 	 	 	 	 5	
	 	 	 Incomplete	resection	with	ablation		 	 2	
	 Inflow	occlusion	 	 	 	 	 	 	 2	
	 Intra-operative	blood	transfusion	 	 	 	 	 1	
	 Intra-operative	frozen	section	performed	 	 	 	 4	
	 Drain	 	 	 	 	 	 	 	 11	
	 Operative	time	(minutes),	median	(range)	 	 	 	 183	(130-375)	
	 ICU	stay	(days),	median	(range)	 	 	 	 	 2	(1-3)	
	 Hospital	stay	(days),	median	(range)	 	 	 	 7	(5-8)	
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